Stock Track | ANTENGENE-B Soars 5.23% Intraday on Insider Buying by Senior Executives

Stock Track

Mar 25

ANTENGENE-B (06996) experienced a significant surge of 5.23% during intraday trading on Wednesday. The sharp upward movement in the biopharmaceutical company's stock price followed the announcement of substantial share purchases by its top management.

The company disclosed that its founder, CEO, and chairman Dr. Jay Mei, along with CFO Donald Andrew Lung and corporate vice president Yang Cao, collectively invested approximately HK$3.85 million to purchase company shares on the open market. Dr. Mei acquired 200,000 shares at an average price of around US$0.512 per share, increasing his stake to approximately 27.16% of the issued share capital.

Management stated that these purchases reflect their firm confidence in Antengene's long-term investment value, robust research and development capabilities, product pipeline, and sustainable growth prospects. The executives indicated they may consider further increasing their holdings in the future, subject to regulatory compliance, reinforcing their commitment to the company's development.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/news/1115910983"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1115910983\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1115910983?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-25 09:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1115910983","market":"nz","top_or_hot":-1,"title":"Stock Track | ANTENGENE-B Soars 5.23% Intraday on Insider Buying by Senior Executives","media":"Stock Track","content":"<p>ANTENGENE-B (06996) experienced a significant surge of 5.23% during intraday trading on Wednesday. The sharp upward movement in the biopharmaceutical company's stock price followed the announcement of substantial share purchases by its top management.</p><p>The company disclosed that its founder, CEO, and chairman Dr. Jay Mei, along with CFO Donald Andrew Lung and corporate vice president Yang Cao, collectively invested approximately HK$3.85 million to purchase company shares on the open market. Dr. Mei acquired 200,000 shares at an average price of around US$0.512 per share, increasing his stake to approximately 27.16% of the issued share capital.</p><p>Management stated that these purchases reflect their firm confidence in Antengene's long-term investment value, robust research and development capabilities, product pipeline, and sustainable growth prospects. The executives indicated they may consider further increasing their holdings in the future, subject to regulatory compliance, reinforcing their commitment to the company's development.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | ANTENGENE-B Soars 5.23% Intraday on Insider Buying by Senior Executives</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | ANTENGENE-B Soars 5.23% Intraday on Insider Buying by Senior Executives\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-25 09:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>ANTENGENE-B (06996) experienced a significant surge of 5.23% during intraday trading on Wednesday. The sharp upward movement in the biopharmaceutical company's stock price followed the announcement of substantial share purchases by its top management.</p><p>The company disclosed that its founder, CEO, and chairman Dr. Jay Mei, along with CFO Donald Andrew Lung and corporate vice president Yang Cao, collectively invested approximately HK$3.85 million to purchase company shares on the open market. Dr. Mei acquired 200,000 shares at an average price of around US$0.512 per share, increasing his stake to approximately 27.16% of the issued share capital.</p><p>Management stated that these purchases reflect their firm confidence in Antengene's long-term investment value, robust research and development capabilities, product pipeline, and sustainable growth prospects. The executives indicated they may consider further increasing their holdings in the future, subject to regulatory compliance, reinforcing their commitment to the company's development.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06996","symbol_name":"德琪医药-B","start_time":0,"source_url":"","article_id":"1115910983","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1115910983","pubTimestamp":1774403477,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"ANTENGENE-B (06996) experienced a significant surge of 5.23% during intraday trading on Wednesday. The sharp upward movement in the biopharmaceutical company's stock price followed the announcement...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06996":"德琪医药-B"},"translate_title":"个股追踪|德琪医药-B盘中暴涨5.23%遭高管内幕买入","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06996":1},"content_text":"ANTENGENE-B (06996) experienced a significant surge of 5.23% during intraday trading on Wednesday. The sharp upward movement in the biopharmaceutical company's stock price followed the announcement of substantial share purchases by its top management.The company disclosed that its founder, CEO, and chairman Dr. Jay Mei, along with CFO Donald Andrew Lung and corporate vice president Yang Cao, collectively invested approximately HK$3.85 million to purchase company shares on the open market. Dr. Mei acquired 200,000 shares at an average price of around US$0.512 per share, increasing his stake to approximately 27.16% of the issued share capital.Management stated that these purchases reflect their firm confidence in Antengene's long-term investment value, robust research and development capabilities, product pipeline, and sustainable growth prospects. The executives indicated they may consider further increasing their holdings in the future, subject to regulatory compliance, reinforcing their commitment to the company's development.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}